Left ventricular ejection performance and systolic muscle function in patients with mitral stenosis.
نویسندگان
چکیده
The status of systolic left ventricular (LV) performance in patients with isolated mitral stenosis (MS) is controversial. Potential alterations in LV architecture as well as loading conditions may have complex effects on LV ejection performance and muscle function. Therefore, we determined hemodynamic and angiographic LV ejection indexes (ejection fraction [EF], velocity of circumferential fiber shortening [Vcf] and stroke work index [SWI]), the level of preload (end-diastolic volume index [EDVII), afterload (end-systolic wall stress [ESS]), and an index ofLV contractile function thought to be independent of loading conditions (end-systolic wall stress/end-systolic volume index [ESS/ESVI]) in nine normal subjects and 16 patients with isolated MS. Although the EF in patients with MS (0.59 ± 0.03) was not statistically different from that in normal subjects (0.66 ± 0.04) (mean ± SEM), 31% ofMS patients had an EF < 0.50. Vcf was lower in MS patients than in normal subjects (1.01 ± 0.06 vs 1.32 ± 0.10 sec-1, p < 0.01), as were SWI (45.0 ± 2.9 vs 69.1 ± 3.9 g-m/m2 p < 0.001) and EDVI (71.3 ± 5.2 vs 93.0 ± 3.9 ml/M2 p < 0.005). End-systolic volume index (ESVI) was similar in MS patients and normal subjects (29.5 ± 3.6 vs 33.0 ± 3.6 ml/m2), whereas stroke volume index (SVI) was lower in MS patients (41.8 ± 2.8 vs 61.6 ± 4.4 ml/M2 p < 0.001). On the basis of ejection performance, MS patients were divided into two groups. Patients with normal ejection perform-
منابع مشابه
Postoperative left ventricular function in patients with mitral stenosis. The effect of commissurotomy and valve replacement on left ventricular systolic function.
Preoperative and postoperative left ventricular cineangiograms of 26 patients with mitral stenosis (MS) were analyzed to calculate left ventricular end-diastolic volume (EDV), end-systolic volume (ESV), stroke volume (SV), ejection fraction (EF) and systolic regional wall motion. Nine patients underwent commissurotomy (OMC group) and 17 patients underwent mitral valve replacement (MVR group). I...
متن کاملComparison of Cardiac Function in Young Patients with Thalassemia Intermedia and Healthy Individuals Using Echocardiography Method
Background: Cardiac dysfunction due to chronic anemia and hemosiderosis are the major causes of death among patients with thalassemia intermedia. This study was performed to compare the cardiac function in thalassemia intermedia patients with normal subjects by means of echocardiography. Materials and Methods: This was a case-control study performed on 22 patients affected by thalassemia int...
متن کاملLeft and right ventricular function during symptom-limited exercise in patients with isolated mitral stenosis.
Ventricular function during exercise in patients with mitral stenosis has not been widely studied. Accordingly, 20 patients with isolated mitral stenosis were assessed during supine, symptom-limited equilibrium radionuclide ventriculographic studies. All patients had a normal left ventricular (LV) ejection fraction at rest (greater than or equal to 50 percent), and all were in sinus rhythm. Lef...
متن کاملThe Relation between Left Ventricular Function and Serum Ferritin in Major Β-Thalassemia
Abstract Objective Cardiac dysfunction is a major cause of death in patients with beta thalassemia. In these patients, repeated blood transfusion, ineffective erythropoiesis and increased gastrointestinal iron absorption lead to iron overload in the body and this induced heart failure. Left ventricular ejection fraction was measured in major beta thalassemia (β-Th) patients to detect the rela...
متن کاملCombined Therapy with Deferiprone and Desferrioxamine as Compared to Desferasirox on Ventricular Function in Thalassemia Major Patients
Abstract Background Myocardial iron overload is the leading cause of death in patients with beta-thalassemia major. Combined therapy with deferiprone(DFP) and desferrioxamine (DFO)were suggested to be more effective than deferasirox(DFX) for removing heart iron. Deferasirox has recently been made available, but its long-term efficacy on cardiac function has not yet been established. Our study...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Circulation
دوره 67 1 شماره
صفحات -
تاریخ انتشار 1983